Patents by Inventor Olga BURENKOVA

Olga BURENKOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
    Patent number: 10184006
    Abstract: Methods for predicting a therapeutic response in a patient (e.g., a cancer patient) to ErbB3 inhibitors, and methods of treating a cancer patient with targeted therapies.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: January 22, 2019
    Assignee: Merrimack Pharmaceuticals, Inc.
    Inventors: Olga Burenkova, Gavin MacBeath, Lin Nie, Mark Sevecka
  • BIOMARKERS FOR PREDICTING OUTCOMES OF CANCER THERAPY WITH ERBB3 INHIBITORS
    Publication number: 20170101480
    Abstract: Methods for predicting a therapeutic response in a patient (e.g., a cancer patient) to ErbB3 inhibitors, and methods of treating a cancer patient with targeted therapies.
    Type: Application
    Filed: June 3, 2016
    Publication date: April 13, 2017
    Inventors: Olga BURENKOVA, Gavin MACBEATH, Lin NIE, Mark SEVECKA